Clinical Trials Directory

Trials / Completed

CompletedNCT04184713

Evaluation of the Effect of an Specific Oral Nutritional Supplement on the Nutritional Status in Cancer and Malnutrition

A Clinical Trial With Nutritional Intervention to Evaluate the Effect of an Specific Oral Nutritional Supplement on the Nutritional Status in Patients With Cancer and Malnutrition

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
160 (actual)
Sponsor
Instituto de Investigación Hospital Universitario La Paz · Academic / Other
Sex
All
Age
28 Years
Healthy volunteers
Not accepted

Summary

Effect of a specific nutritional oral supplement on the nutritional status of patients with cancer and malnutrition

Detailed description

Multicentric, parallel, randomized, double blind and controlled clinical-nutritional study of 8 weeks of duration and 2 study groups of treatment: Experimental group (experimental nutritional oral supplement); and Control group (control nutritional oral supplement) to evaluate the effect on the nutritional and functional status, the quality of life and body composition of patients with cancer and malnutrition undergoint specficic treatment (chemotherapy, radiotherapy, inmunotherapy).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTExperimental GroupNutritional intervention and physical activity recommendations. Consumption of 2 tetra paks/day of a specific oral nutritional supplement (hypercaloric/hyperproteic with fiber and omega-3 enriched, with L-leucine, betaglucans and medium chain triglycerides) for 8 weeks.
DIETARY_SUPPLEMENTControl GroupNutritional intervention and physical activity recommendations. Consumption of 2 tetra paks/day of a specific oral nutritional supplement (hypercaloric/hyperproteic with fiber) for 8 weeks.

Timeline

Start date
2019-10-01
Primary completion
2020-08-01
Completion
2020-08-01
First posted
2019-12-04
Last updated
2021-07-20

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04184713. Inclusion in this directory is not an endorsement.